‹ All Posts
Sumit Kadam

24th Feb · SEBI-Registered Analyst

India Inc Salary Growth Seen Moderating in 2026; GCCs and Pharma Lead Increments.

TCS
: Benefits from GCC expansion and tech talent demand.
SUNPHARMA
: Pharma sector expected to grant higher pay due to strong global demand.
DRREDDY
: Export-oriented pharma firms remain competitive for skilled workforce. Salary hikes across corporate India are projected to soften in 2026 compared to prior years. However, Global Capability Centres and pharmaceutical companies are likely to offer stronger increments due to specialized skill shortages and steady business momentum. Investors track wage trends as they influence margins, hiring cycles, and sector competitiveness. Lower increments can support cost control, while higher hikes in select sectors signal sustained demand and growth visibility. Projected average salary increase for 2026: about 9.1%. Divergence in salary trends highlights which sectors face talent scarcity versus cost pressure, offering clues about underlying business momentum. Disclaimer: This article is for informational and educational purposes only. It does not constitute investment advice.

#Pre-OpeningCommentary#FundamentalViews#WatchOutFor#StockInNews#PersonalFinance
1,005 likes·67 comments